Revenue
2020
2021
2022
2023
2024
2025
Transgene S.a. (TNG)
Price€0.8620Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €7.2M | €6.4M | €7.9M | €10.3M | €10.0M | €3.0M |
| Research & development | €33.9M | €34.3M | €29.6M | €32.2M | €32.9M | €27.3M |
| Operating expenses | €42.3M | €42.0M | €37.9M | €40.2M | — | — |
| Operating income | −€35.1M | −€35.7M | −€30.0M | −€29.9M | −€23.5M | −€24.0M |
| Operating margin | −486.26% | −561.28% | −380.34% | −289.10% | −235.41% | −804.86% |
| EBITDA | −€33.7M | −€34.4M | −€28.5M | −€28.2M | −€21.0M | — |
| EBITDA margin | −467.86% | −541.11% | −360.44% | −272.80% | −210.19% | — |
| Net income | −€37.5M | −€34.0M | −€22.3M | −€32.8M | −€19.5M | −€17.2M |
| Net profit margin | −520.44% | −534.72% | −282.63% | −317.13% | −195.50% | −578.03% |
| Basic EPSper basic share | -€0.26 | -€0.29 | -€0.22 | -€0.33 | -€0.21 | -€0.21 |
| Diluted EPSper diluted share | -€0.26 | -€0.29 | -€0.22 | -€0.33 | -€0.21 | -€0.21 |